Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3858 results

Sort By:

Office Massage Effects on HRV and Stress

Study ID: NCT07272031
Start Date: 2026-01-05
End Date: 2027-04
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

140

Intervention / Treatment

Head Massage Intervention

Cervical Area Massage Intervention

Hand Massage Intervention

Quiet Rest Control

Sponsor

Riga Stradins University

Source: clinicaltrials.gov

Share:
Add to list

Cognition and Patients With Lung Cancer

Study ID: NCT07160751
Start Date: 2026-01
End Date: 2029-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Self-questionnaire

Cognitive tests

Assessment of the impact of social vulnerability on patient complaints

Sponsor

Public Assistance - Paris Hospitals

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of an Enhanced Recovery After Surgery Protocol in Patients Undergoing On-pump Cardiac Surgery

Study ID: NCT05225272
Start Date: 2026-09-01
End Date: 2027-09-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

92

Intervention / Treatment

Enhanced Recovery Program for on-pump cardiac surgery

Sponsor

Hospital Center of the University of Montreal (CHUM)

Source: clinicaltrials.gov

Share:
Add to list

Facilitated Telemedicine in the Catholic Health System

Study ID: NCT06483451
Start Date: 2026-01
End Date: 2026-04
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment
Sponsor

State University of New York at Buffalo

Source: clinicaltrials.gov

Share:
Add to list

Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

Study ID: NCT07291102
Start Date: 2026-07-01
End Date: 2038-10
Study Type

Interventional

Study Phase

Phase3

No. of Participants

96

Intervention / Treatment

Bridging Chemotherapy

Induction Cycles A1-A3

Induction Cycles A4-5

Consolidation Cycle A6

HIT-SKK Chemotherapy Cycles B1-3

Modified HIT-SKK Cycle B4-5

Sponsor

Nationwide Children's Hospital

Source: clinicaltrials.gov

Share:
Add to list

Application to Predict Neonatal Apnea With Bradycardia

Study ID: NCT06852053
Start Date: 2026-01-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Closed-loop Vibro-Tactile Stimulator

Control

Sponsor

University of Alabama at Birmingham

Source: clinicaltrials.gov

Share:
Add to list

Sugary Drink Labeling Study

Study ID: NCT07294053
Start Date: 2026-02
End Date: 2028-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

543

Intervention / Treatment

Added sugar warning

Control label

Sponsor

University of North Carolina, Chapel Hill

Source: clinicaltrials.gov

Share:
Add to list

Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)

Study ID: NCT06234345
Start Date: 2026-09
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1252

Intervention / Treatment

Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg

Comparator - Trimbow®

Sponsor

Eurofarma Laboratorios S.A.

Source: clinicaltrials.gov

Share:
Add to list

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

Study ID: NCT07252739
Start Date: 2026-01-14
End Date: 2033-01-14
Study Type

Interventional

Study Phase

Phase2

No. of Participants

130

Intervention / Treatment

MK-1084

Pembrolizumab

Cetuximab

Carboplatin

Pemetrexed

Sponsor

Merck Sharp & Dohme LLC

Source: clinicaltrials.gov

Share:
Add to list

Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level

Study ID: NCT07170735
Start Date: 2026-01-01
End Date: 2027-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

85

Intervention / Treatment

Plasma MTB cfDNA assay

Urine MTB cfDNA assay

Sponsor

Chinese University of Hong Kong

Source: clinicaltrials.gov

Share:
Add to list